Manufacturer of the original drug Vancevir (valganciclovir)

When we talk about the highly effective antiviral drug Valganciclovir (Valganciclovir), we have to mention the R&D giant behind it - the Swiss pharmaceutical company Roche (Roche). Roche is not only a world-renowned pharmaceutical company, but also has made world-renowned contributions to the research and development of antiviral drugs. Vancevir (valganciclovir) is one of its outstanding masterpieces, specifically targeting the prevention and treatment of cytomegalovirus (CMV) infection.

The core ingredient of Valganciclovir (valganciclovir) will be converted into ganciclovir after oral administration. This substance can accurately inhibit the viral DNA polymerase, thereby blocking the further extension of the viral DNA chain and effectively curbing the replication activity of CMV. It is precisely because of this high specificity and powerful inhibitory ability against CMV that Valganciclovir (valganciclovir) performs particularly well in patients with low immune function.

For patients who have just received an organ transplant, they are more susceptible to CMV due to the need for immunosuppressive treatment. At this time, Valganciclovir is like a patron saint, helping them prevent CMV infection and thereby reduce various complications caused by infection. Similarly, for those HIV infected patients, especially those whose immune systems have been severely damaged, Valganciclovir (valganciclovir) can effectively prevent and treat retinitis and other diseases that may be caused by CMV infection, protecting their health.

Every tablet of Vancevir (valganciclovir) produced by Roche has undergone strict international quality standards inspection and clinical trial verification to ensure that its efficacy and safety meet global unified standards. As an original drug, the research and development process behind it includes countless trials and explorations, just to find the most suitable medication regimen and dosage for patients.

However, as an imported original drug, Vancevir (valganciclovir) The price is not close to the people, and the price in the Chinese market is as high as more than 10,000 yuan. But thankfully, there are more affordable Indian and Turkish versions of the original drugs on the market for patients to choose from. Their prices are only three to four thousand yuan, and their efficacy and ingredients are the same as the original drugs.

In general, Vancevir (valganciclovir) developed by Roche Pharmaceutical Company not only brings hope to CMV infected patients, but also wins the trust of patients with its excellent efficacy and safety. Despite its high price tag, it remains the drug of choice for many patients in the current market environment. When choosing, patients should make the most informed decision based on their actual situation and financial ability.